-
1 Comment
Qianhai Health Holdings Limited is currently in a long term downtrend where the price is trading 10.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Qianhai Health Holdings Limited's total revenue sank by 30.7% to $371M since the same quarter in the previous year.
Its net income has dropped by 141.4% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 101.1% to $2M since the same quarter in the previous year.
Based on the above factors, Qianhai Health Holdings Limited gets an overall score of 2/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Sector | Healthcare |
| Exchange | HK |
| CurrencyCode | HKD |
| ISIN | KYG7307F1046 |
| Market Cap | 37M |
|---|---|
| PE Ratio | 28.42 |
| Target Price | None |
| Beta | 0.01 |
| Dividend Yield | None |
Qianhai Health Holdings Limited, an investment holding company, engages in the trading and sale of health-care products in Hong Kong. The company offers Chinese herbal medicines and other health care products; and administrative services. It also trades in ginseng wine and other healthy food products. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0911.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
